Coherus BioSciences Reports Second Quarter 2016 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Coherus BioSciences Reports Second Quarter 2016 Financial and Operating Results

Coherus BioSciences (CHRS) Reports Q4 Loss of $1.72/Share

August 9, 2016 4:20 PM EDT

Coherus BioSciences (NASDAQ: CHRS) reported Q4 EPS of ($1.72), versus ($1.56) reported last year. Revenue for the quarter came in at $14.07 million, versus $6.87 million reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.

... More